Lively Biotech has obtained optimistic suggestions from regulators on a protocol modification to its ongoing proof-of-concept scientific trial evaluating tasquinimod in sufferers with myelofibrosis, a...
The U.S. Meals and Drug Administration (FDA) has accepted PD-L1 IHC 22C3 pharmDx, Code SK006, as a companion diagnostic to assist establish sufferers with epithelial...
Pamela Kunz stated she left Stanford Faculty of Drugs due to years of gender-related microaggressions and verbal abuse she skilled there. She wasn’t...
The FDA has accepted pembrolizumab for the first-line therapy of sure HER2-negative gastric and gastroesophageal junction cancers.
The U.S. Meals and Drug Administration (FDA)...
Martinez-Ferriz A, Ferrando A, Fathinajafabadi A, Farras R. Ubiquitin-mediated mechanisms of translational management. Semin Cell Dev Biol. 2022;132:146–54.Article
CAS
...
